Hospital
Christian Hospital Northeast- Northwest
Christian Hospital Northeast- Northwest was paid $65.26M by Medicaid between Jan 2018 and Dec 2024, across 138 billing codes. Its largest line is X4011, State-specific procedure code — 22% of everything it billed.
33Billing provider infoCHRISTIAN HOSPITAL NORTHEAST- NORTHWEST
SAINT LOUIS, MO 63136
SAINT LOUIS, MO 63136
33aNPI1639186760assigned 08/02/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$65.26M
24GClaims647,341
24DCodes billed138
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Missouri
Rank by total paid#2 of 9
Median peer was paid$8.82M
This provider vs. median7.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,139 | $9.73M | |
| 2019 | 75,245 | $14.10M | |
| 2020 | 61,247 | $9.29M | |
| 2021 | 96,888 | $5.40M | |
| 2022 | 123,389 | $8.44M | |
| 2023 | 129,353 | $10.31M | |
| 2024incomplete | 100,080 | $7.99M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X4011 | State-specific procedure code | 22% | 34,165 | 31,882 | $14.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 83,666 | 80,771 | $14.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 35,550 | 33,591 | $7.31M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.5% | 22,333 | 20,795 | $6.20M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.4% | 17,962 | 16,841 | $2.25M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.4% | 77,015 | 71,529 | $2.20M |
| 80053 | Comprehensive metabolic panel | 3.0% | 71,273 | 66,515 | $1.94M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.8% | 18,781 | 18,397 | $1.80M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 29,660 | 27,382 | $1.47M |
| 81001 | 2.0% | 31,339 | 29,860 | $1.30M | |
| Y7507 | 1.8% | 5,820 | 5,211 | $1.18M | |
| 81025 | 1.8% | 20,407 | 19,651 | $1.17M |
126 more codes
| 71045 | Radiologic examination, chest; single view | 1.4% | 21,663 | $887K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.2% | 2,265 | $763K |
| 87631 | 1.1% | 2,266 | $703K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 10,592 | $557K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,836 | $411K |
| X4006 | <1% | 613 | $403K | |
| 84484 | <1% | 18,035 | $400K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,716 | $386K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,006 | $381K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 11,443 | $360K |
| Y7506 | <1% | 1,187 | $347K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,687 | $330K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,778 | $269K |
| 83690 | <1% | 9,346 | $257K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,443 | $254K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,276 | $246K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,013 | $243K |
| 87070 | <1% | 792 | $213K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 5,871 | $194K |
| 81003 | <1% | 8,207 | $160K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,595 | $157K |
| 87807 | <1% | 457 | $129K | |
| 83880 | <1% | 3,723 | $124K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,946 | $109K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,146 | $106K |
| 82150 | <1% | 1,061 | $94K | |
| X4003 | <1% | 1,480 | $91K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 683 | $90K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,892 | $90K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,821 | $89K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 597 | $79K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,679 | $75K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 612 | $63K |
| 80061 | Lipid panel | <1% | 5,066 | $63K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 618 | $53K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,679 | $50K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 837 | $44K |
| 83735 | <1% | 2,842 | $44K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 586 | $34K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 518 | $34K |
| 85610 | <1% | 1,068 | $24K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 612 | $22K |
| 87808 | <1% | 471 | $21K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,277 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,579 | $20K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 319 | $19K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,084 | $18K |
| J3490 | Unclassified drugs | <1% | 10,837 | $17K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 804 | $17K |
| 84702 | <1% | 867 | $17K | |
| 82077 | <1% | 1,551 | $16K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 119 | $11K |
| 97161 | <1% | 360 | $8K | |
| 85730 | <1% | 294 | $8K | |
| 87077 | <1% | 327 | $8K | |
| 62323 | <1% | 106 | $7K | |
| 83605 | <1% | 957 | $7K | |
| 85379 | <1% | 638 | $7K | |
| 84439 | <1% | 955 | $6K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 13 | $6K |
| 74019 | <1% | 25 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 55 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 40 | $4K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 147 | $4K |
| 87536 | <1% | 67 | $4K | |
| 80143 | <1% | 274 | $3K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 157 | $3K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 161 | $3K |
| 82043 | <1% | 498 | $3K | |
| 80179 | <1% | 206 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 75 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 76 | $2K |
| 87510 | <1% | 121 | $2K | |
| 87480 | <1% | 121 | $2K | |
| 84550 | <1% | 643 | $2K | |
| 94010 | <1% | 31 | $2K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 49 | $2K |
| 82570 | <1% | 464 | $2K | |
| 87660 | <1% | 109 | $2K | |
| 80050 | General health panel | <1% | 71 | $2K |
| 20610 | <1% | 16 | $2K | |
| 73630 | <1% | 24 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,342 | $2K |
| 73564 | <1% | 29 | $2K | |
| 85027 | <1% | 332 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 66 | $1K |
| 62368 | <1% | 27 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $1K |
| 82607 | <1% | 101 | $984.43 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 16 | $946.03 |
| 72100 | <1% | 106 | $804.60 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 17 | $718.45 |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 28 | $651.24 |
| 73610 | <1% | 12 | $595.83 | |
| 87040 | <1% | 41 | $479.98 | |
| 73030 | <1% | 14 | $462.92 | |
| 86706 | <1% | 45 | $397.47 | |
| 88342 | <1% | 13 | $381.43 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 30 | $361.00 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 12 | $330.96 |
| 86704 | <1% | 31 | $301.64 | |
| 82550 | <1% | 54 | $277.72 | |
| 87340 | <1% | 29 | $239.50 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 79 | $187.50 |
| 86300 | <1% | 12 | $183.04 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 13 | $129.49 |
| 73130 | <1% | 14 | $105.16 | |
| 86803 | <1% | 12 | $102.69 | |
| 82010 | <1% | 12 | $69.84 | |
| 86592 | <1% | 16 | $69.32 | |
| 87184 | <1% | 12 | $39.72 | |
| 85049 | <1% | 12 | $39.70 | |
| 82962 | <1% | 12 | $25.97 | |
| 86901 | <1% | 15 | $22.94 | |
| 85048 | <1% | 12 | $22.54 | |
| 86900 | <1% | 15 | $22.36 | |
| 85018 | <1% | 12 | $20.99 | |
| 85014 | <1% | 12 | $20.99 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 18 | $5.82 |
| 97116 | <1% | 27 | $3.47 | |
| A4215 | Needle, sterile, any size, each | 0% | 51 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 25 | $0.00 |
| C1755 | Catheter, intraspinal | 0% | 28 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIROVIC, PAUL (VICE PRESIDENT, FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Barnes Jewish Hospital | Saint Louis, MO | $61.34M |
| Barnes Jewish Hospital | Saint Louis, MO | $56K |
| Barnes Jewish Hospital | Saint Louis, MO | $20K |
| Barnes Jewish Hospital | Saint Louis, MO | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.